Metastatic colonization: Settlement, adaptation and propagation of tumor cells in a foreign tissue environment

Seminars in Cancer Biology

Volumn 21, Issue 2, 2011, Pages 99-106

  Shibue, Tsukasa ^a,b   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Colonization; Dormancy; Extravasation; Metastasis; Tumor host interactions

Indexed keywords

FIBRINOGEN; FOCAL ADHESION KINASE; HERMES ANTIGEN; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

BREAST CANCER; CELL ADHESION; CELL INTERACTION; CELL PROLIFERATION; CELL SURFACE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; EXTRAVASATION; HUMAN; LUNG METASTASIS; MELANOMA CELL; METASTASIS; MICROMETASTASIS; NONHUMAN; REVIEW; SHEAR STRESS; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL PROLIFERATION; HUMANS; NEOPLASM METASTASIS; NEOPLASM SEEDING; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TUMOR MICROENVIRONMENT;

EID: 79952073683     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2010.12.003     Document Type: Review

References (84)

1. Talmadge J.E., Fidler I.J. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 2010, 70:5649-5669.
2. Klein C.A. Parallel progression of primary tumours and metastases. Nat Rev Cancer 2009, 9:302-312.
3. Engel J., Eckel R., Kerr J., Schmidt M., Furstenberger G., Richter R., et al. The process of metastasisation for breast cancer. Eur J Cancer 2003, 39:1794-1806.
4. Orr F.W., Wang H.H., Lafrenie R.M., Scherbarth S., Nance D.M. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000, 190:310-329.
5. Gassmann P., Haier J. The tumor cell-host organ interface in the early onset of metastatic organ colonisation. Clin Exp Metastasis 2008, 25:171-181.
6. Miles F.L., Pruitt F.L., van Golen K.L., Cooper C.R. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 2008, 25:305-324.
7. Pantel K., Alix-Panabieres C., Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009, 6:339-351.
8. Hedley B.D., Chambers A.F. Tumor dormancy and metastasis. Adv Cancer Res 2009, 102:67-101.
9. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010, 10:9-22.
10. Weiss L., Orr F.W., Honn K.V. Interactions of cancer cells with the microvasculature during metastasis. FASEB J 1988, 2:12-21.
11. Meng S., Tripathy D., Frenkel E.P., Shete S., Naftalis E.Z., Huth J.F., et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004, 10:8152-8162.
12. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998, 153:865-873.
13. Steinbauer M., Guba M., Cernaianu G., Kohl G., Cetto M., Kunz-Schughart L.A., et al. GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice. Clin Exp Metastasis 2003, 20:135-141.
14. Schluter K., Gassmann P., Enns A., Korb T., Hemping-Bovenkerk A., Holzen J., et al. Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. Am J Pathol 2006, 169:1064-1073.
15. Simon S.I., Green C.E. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 2005, 7:151-185.
16. Dimitroff C.J., Lechpammer M., Long-Woodward D., Kutok J.L. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res 2004, 64:5261-5269.
17. Haier J., Korb T., Hotz B., Spiegel H.U., Senninger N. An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J Gastrointest Surg 2003, 7:507-514. [discussion 514-5].
18. Ito S., Nakanishi H., Ikehara Y., Kato T., Kasai Y., Ito K., et al. Real-time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene-tagged rat tongue carcinoma cell line. Int J Cancer 2001, 93:212-217.
19. Glinskii O.V., Huxley V.H., Glinsky G.V., Pienta K.J., Raz A., Glinsky V.V. Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia 2005, 7:522-527.
20. Garofalo A., Chirivi R.G., Foglieni C., Pigott R., Mortarini R., Martin-Padura I., et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res 1995, 55:414-419.
21. Okahara H., Yagita H., Miyake K., Okumura K. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res 1994, 54:3233-3236.
22. Lehr J.E., Pienta K.J. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 1998, 90:118-123.
23. Scott L.J., Clarke N.W., George N.J., Shanks J.H., Testa N.G., Lang S.H. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 2001, 84:1417-1423.
24. Brown D.M., Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004, 5:365-374.
25. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
26. Murakami T., Cardones A.R., Finkelstein S.E., Restifo N.P., Klaunberg B.A., Nestle F.O., et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 2003, 198:1337-1347.
27. Hejna M., Raderer M., Zielinski C.C. Inhibition of metastases by anticoagulants. J Natl Cancer Inst 1999, 91:22-36.
28. Im J.H., Fu W., Wang H., Bhatia S.K., Hammer D.A., Kowalska M.A., et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 2004, 64:8613-8619.
29. Konstantopoulos K., Thomas S.N. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 2009, 11:177-202.
30. Camerer E., Qazi A.A., Duong D.N., Cornelissen I., Advincula R., Coughlin S.R. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 2004, 104:397-401.
31. Rickles F.R., Patierno S., Fernandez P.M. Tissue factor, thrombin, and cancer. Chest 2003, 124:58S-68S.
32. Kim Y.J., Borsig L., Varki N.M., Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 1998, 95:9325-9330.
33. Liotta L.A., Saidel M.G., Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976, 36:889-894.
34. Roberts K.E., Hamele-Bena D., Saqi A., Stein C.A., Cole R.P. Pulmonary tumor embolism: a review of the literature. Am J Med 2003, 115:228-232.
35. Talmadge J.E., Wolman S.R., Fidler I.J. Evidence for the clonal origin of spontaneous metastases. Science 1982, 217:361-363.
36. Strell C., Entschladen F. Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal 2008, 6:10.
37. Muller W.A., Randolph G.J. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 1999, 66:698-704.
38. Kramer R.H., Nicolson G.L. Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. Proc Natl Acad Sci USA 1979, 76:5704-5708.
39. Aird W.C. Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms. Circ Res 2007, 100:158-173.
40. Honn K.V., Grossi I.M., Diglio C.A., Wojtukiewicz M., Taylor J.D. Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction. FASEB J 1989, 3:2285-2293.
41. Tang D.G., Chen Y.Q., Diglio C.A., Honn K.V. Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor. J Cell Biol 1993, 121:689-704.
42. Honn K.V., Tang D.G., Grossi I., Duniec Z.M., Timar J., Renaud C., et al. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res 1994, 54:565-574.
43. Uchide K., Sakon M., Ariyoshi H., Nakamori S., Tokunaga M., Monden M. Cancer cells cause vascular endothelial cell (vEC) retraction via 12(S)HETE secretion; the possible role of cancer cell derived microparticle. Ann Surg Oncol 2007, 14:862-868.
44. Offner F.A., Schiefer J., Wirtz H.C., Bigalke I., Pavelka M., Hollweg G., et al. Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage. Virchows Arch 1996, 428:99-106.
45. Soares F.A., Shaughnessy S.G., MacLarkey W.R., Orr F.W. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo. Lab Invest 1994, 71:480-489.
46. Weis S., Cui J., Barnes L., Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004, 167:223-229.
47. Lee T.H., Avraham H.K., Jiang S., Avraham S. Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J Biol Chem 2003, 278:5277-5284.
48. Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007, 446:765-770.
49. Minn A.J., Kang Y., Serganova I., Gupta G.P., Giri D.D., Doubrovin M., et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005, 115:44-55.
50. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., Muschel R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000, 6:100-102.
51. Zhang Q., Yang M., Shen J., Gerhold L.M., Hoffman R.M., Xing HR The role of the intravascular microenvironment in spontaneous metastasis development. Int J Cancer 2010, 126:2534-2541.
52. Vaage J., Harlos J.P. Spontaneous metastasis from primary C3H mouse mammary tumors. Cancer Res 1987, 47:547-550.
53. Morris V.L., Koop S., MacDonald I.C., Schmidt E.E., Grattan M., Percy D., et al. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis 1994, 12:357-367.
54. Naumov G.N., MacDonald I.C., Weinmeister P.M., Kerkvliet N., Nadkarni K.V., Wilson S.M., et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 2002, 62:2162-2168.
55. Podsypanina K., Du Y.C., Jechlinger M., Beverly L.J., Hambardzumyan D., Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008, 321:1841-1844.
56. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572.
57. Guo W., Giancotti F.G. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004, 5:816-826.
58. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
59. Shibue T., Weinberg R.A. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 2009, 106:10290-10295.
60. Barkan D., Kleinman H., Simmons J.L., Asmussen H., Kamaraju A.K., Hoenorhoff M.J., et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 2008, 68:6241-6250.
61. Yu Q., Toole B.P., Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997, 186:1985-1996.
62. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
63. de Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006, 6:24-37.
64. Gandhi M.J., Strong D.M. Donor derived malignancy following transplantation: a review. Cell Tissue Bank 2007, 8:267-286.
65. Killion J.J., Fidler I.J. Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators. Pharmacol Ther 1998, 78:141-154.
66. Eyles J., Puaux A.L., Wang X., Toh B., Prakash C., Hong M., et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010, 120:2030-2039.
67. Takeda K., Hayakawa Y., Smyth M.J., Kayagaki N., Yamaguchi N., Kakuta S., et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001, 7:94-100.
68. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
69. Achilles E.G., Fernandez A., Allred E.N., Kisker O., Udagawa T., Beecken W.D., et al. Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for " no take" of human tumors in mice. J Natl Cancer Inst 2001, 93:1075-1081.
70. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18.
71. Yin J.J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Wieser R., et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 1999, 103:197-206.
72. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
73. Park B.K., Zhang H., Zeng Q., Dai J., Keller E.T., Giordano T., et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 2007, 13:62-69.
74. Roodman G.D. Mechanisms of bone metastasis. N Engl J Med 2004, 350:1655-1664.
75. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2:584-593.
76. Ibrahim T., Flamini E., Mercatali L., Sacanna E., Serra P., Amadori D. Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer 2010, 116:1406-1418.
77. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827.
78. Hiratsuka S., Watanabe A., Aburatani H., Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006, 8:1369-1375.
79. Erler J.T., Bennewith K.L., Cox T.R., Lang G., Bird D., Koong A., et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 2009, 15:35-44.
80. McAllister S.S., Gifford A.M., Greiner A.L., Kelleher S.P., Saelzler M.P., Ince T.A., et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 2008, 133:994-1005.
81. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889, 1:571-573.
82. Bross I.D., Viadana E., Pickren J.W. The metastatic spread of myeloma and leukemias in men. Virchows Arch A: Pathol Anat Histol 1975, 365:91-101.
83. Weigelt B., Bissell M.J. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008, 18:311-321.
84. Weigert R., Sramkova M., Parente L., Amornphimoltham P., Masedunskas A. Intravital microscopy: a novel tool to study cell biology in living animals. Histochem Cell Biol 2010, 133:481-491.